HPV Self-sampling in the General Population

Recruiting N/A Interventional Study
Cervical Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 65
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
6,000 (estimated)
Sponsor
International Agency for Research on Cancer · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit ("Outreach" arm), choice between self-sampling or healthcare provider sampling ("Choice" arm), and standard care (control arm) in two French departments.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women aged 30 to 65 years old * Living in the study area (Departments of Marne and Aube, France) * At moderate risk of cervical cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter) Exclusion Criteri…
Contacts

Farida Selmouni, PhD

+33 4 72738485

selmounif@iarc.who.int

CONTACT

Catherine Sauvaget, MD, PhD

+33 4 72738485

sauvagetc@iarc.who.int

CONTACT